DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Genetic Disorder

Duchenne Muscular Dystrophy (DMD)

HIGH SEVERITY

An X-linked recessive disorder caused by mutations in the DMD gene encoding dystrophin, essential for muscle fiber integrity. Primarily affects males (1 in 3,500-5,000 male births), causing progressive muscle degeneration and weakness.

Global Affected

250.0K

Countries

15

Symptoms

Muscle weakness starting in legs/pelvis
Difficulty walking
Frequent falls
Waddling gait
Muscle atrophy
Cardiomyopathy
Respiratory failure

Treatment Options

Genetic counseling
Supportive care
Symptom management
Enzyme replacement (if applicable)
Physical therapy
Regular monitoring
Multidisciplinary care

Risk Factors

1Family history
2Genetic mutations
3Consanguinity
4Advanced paternal age
5Ethnic predisposition

Diagnostic Methods

  • 1Genetic testing
  • 2Clinical evaluation
  • 3Family history assessment
  • 4Specialized laboratory tests
  • 5Imaging studies
  • 6Biopsy (if applicable)

Prognosis

Progressive muscle weakness. Loss of ambulation by age 12 without steroids, 16 with steroids. Respiratory and cardiac involvement in late teens. Death typically in 20s-30s from cardiac or respiratory failure. Newer therapies extending lifespan.

Prevention

  • Genetic counseling
  • Carrier screening
  • Prenatal diagnosis
  • Preimplantation genetic diagnosis
  • Family planning

Research Status

Exon-skipping drugs (Exondys 51, Vyondys 53, Amondys 45) approved. Gene therapy (Elevidys) FDA-approved. CRISPR clinical trials ongoing. Corticosteroids extend ambulation.

Sources

  • https://www.ncbi.nlm.nih.gov/books/NBK1116
  • https://medlineplus.gov/genetics
  • https://rarediseases.org

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.